← Open Payments lookup

RACHEL KING: Open Payments

NPI 1205826245 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,745 in 21 payments from 7 companies in 2025. Trend: 2023 $592 · 2024 $1,253 · 2025 $1,745

Consulting: $1,140Food & beverage: $436Education: $169
CompanyPaymentsAmount
UCB, Inc.5$1,252
Novartis Pharmaceuticals Corporation9$230
Janssen Biotech, Inc.3$107
SANOFI-AVENTIS U.S. LLC1$97
GENZYME CORPORATION1$23
Galderma Laboratories, L.P.1$22
Amgen Inc.1$14

Products named: Bimzelx, Rhapsido, DUPIXENT, TREMFYA, XOLAIR, NEMLUVIO, OTEZLA.

Industry payments across ID — which companies pay providers there.